Lippincott Williams & Wilkins Total Access Collection with Neurology

The University of Cambridge Journals Co-ordination Scheme is delighted to provide access from 2018/2019 to the Lippincott Williams & Wilkins “Total Access Collection with Neurology”.

The LWW Total Access Collection is a collection of all LWW journals available on the Ovid platform.

LWW journals are highly respected in clinical medicine, and range from essential core journals to specialized resources in such areas as nursing and bioscience.

All titles in the collection can be found in iDiscover, as can article indexing for the journals in the collection.  A browsable list of journals is provided from the Cambridge LibGuides A-Z here:

New e-resource: Global Health database

The Medical Library and the University Library have arranged access for the University to the Global Health database, aka CABI Global Health.

Access is available for 4 users simultaneously.   Once you have finished using the database please log out of it.

Global Health is available via this link or via the Cambridge LibGuides Databases A-Z

Produced by CABI, this database was created to ensure that key literature from all sources can be brought quickly and easily to the attention of those working in the field. The database covers all aspects of public health at both international and community levels, as well as a wealth of material from other biomedical and life science fields.

A promotional flyer is available here to help promote this resource in your library.

Global Health is the only specialized bibliographic, abstracting and indexing database dedicated to public health, completing the picture of international medical and health research by capturing key literature that is not covered by other databases, providing users with a truly global perspective.

Literature in this database is selected by subject specialists to include only relevant papers, and content is directed by an international editorial advisory board. Global Health covers journals, such as BMA (British Medical Association), Evidence-Based Practice for Public Health (Lamar Soutter Library, Massachusetts), Core Public Health Journals Project (US Medical Library Association) and World Public Health Association.

About CABI:

CABI is not like most other publishers. Our commitment to publishing databases, books and other information resources is not driven by profit. We are a not-for-profit organization with a mission that has scientific research and international development at its core. CABI improves lives worldwide by providing information and applying scientific expertise to solve problems in agriculture and the environment.

More than 800 million people in developing countries live in rural areas–the majority relying entirely on what they can grow themselves in order to survive. Through our work, not only are
scientists and institutions provided with the knowledge they need to support their own work, but also smallholder farmers are helped to lose less of their crops to pests and diseases,
improve crop quality and yield, and create better livelihoods for their familes.

Journal of the American Society of Echocardiography


From the journal’s Aims and Scope page:

“The Journal of the American Society of Echocardiography(JASE) brings physicians and sonographers peer-reviewed original investigations and state-of-the-art review articles that cover conventional clinical applications of cardiovascular ultrasound, as well as newer techniques with emerging clinical applications. These include three-dimensional echocardiography, strain and strain rate methods for evaluating cardiac mechanics and interventional applications.”

Now available to University of Cambridge users from volume 8 (1995) to present.

Access Journal of the American Society of Echocardiography via the ejournals@cambridge A-Z or at this link.

BMJ Best Practice

The University Library has arranged access for the students of the Medical School to the BMJ Best Practice resource. 

BMJ BP is a “point of care” tool designed to support clinicians in their decision making from diagnosis to treatment.  It is delivered online or as the BMJ Best Practice decision support app for iOS (iPad/iPhone) and Android mobile device platforms.

Access is available on campus via this link:

Or off campus via this link:


Produced by the BMJ Evidence Centre, BMJ BP aims to be a readily accessible single source for up-to-date research evidence, guidelines, and expert thought, offering an instantly available second opinion.

Entries on medical conditions consist of basic information (definitions, epidemiology, etc.), prevention, guidelines and step-by-step information for diagnosis and treatment, and follow-up recommendations.


Guides and promotional materials are available:

Getting started with BMJ Best Practice

Best practice poster

Decision support in your pocket poster

BP, the app



BMJ Best Practice Trial

Trial access is now available for 1 month from today 11 January to 9 February 2016 to the BMJ Best Practice resource for healthcare professionals targeted at point-of-care decision support.

BMJ Best Practice collates regularly updated research evidence with guidelines and the
knowledge of international experts, offering a step-by-step approach to clinical problems throughout the patient journey.

Access is available on campus via this link:

Or off campus via this link:

If you are an NHS user you can access via your NHS Athens login.

Alternatively consult and use BMJ Best Practice via the decision support App.  Sign in via Shibboleth on your mobile device to download the App from the Google Play or Apple iStore.  For more detailed information please consult the BMJ page here (see section 2).

Please send feedback to the Medical Library by writing to

If you have any access or technical issue with the trial please contact the ejournals & eresources helpdesk by writing to

Please let us know what you think about BMJ Best Practice.  Thank you.

Reaxys Medicinal Chemistry

New resource:  Reaxys Medicinal Chemistry

Reaxys Medicinal Chemistry empowers hit identification and lead optimization with normalized compound–target affinity data and comprehensive pharmacokinetic, efficacy, toxicity, safety and metabolic profiles.

Reaxys Medicinal Chemistry combines the world’s largest and best-organized compound bioactivity data with tools for hitset assessment and the possibilities to export data to existing computational environments to facilitate harmonized analysis of in-house and external data.

Access Reaxys Medicinal Chemistry from this link.

Reaxys Medicinal Chemistry trial

The University of Cambridge has trial access to Reaxys Medicinal Chemistry until 31 October 2014.

Access Reaxys Medicinal Chemistry via the Reaxys interface here.

Please send your feedback on the trial to

Reaxys Medicinal Chemistry combines the Reaxys chemistry database with tools for hitset assessment and data export.  It is designed to support researchers in making connections between compounds, targets, and bioactivity, allowing rapid early-stage drug candidate assessment.